THE BURDEN OF PERSISTENT COUGH IN IDIOPATHIC PULMONARY FIBROSIS (IPF) AND OTHER INTERSTITIAL LUNG DISEASES (ILD): A SYSTEMATIC EVIDENCE SYNTHESIS

被引:0
|
作者
Green, R. [1 ]
Baldwin, M. [2 ]
Pooley, N. [3 ]
Rutten-van Molken, M. [4 ]
Patel, N. [5 ]
Wijsenbeek, M. S. [6 ]
机构
[1] Maverex, Manchester, Greater Manches, England
[2] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[3] Maverex Ltd, Manchester, Greater Manches, England
[4] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, South Holland, Netherlands
[5] Boehringer Ingelheim Int GmbH, Ridgefield, CT USA
[6] Erasmus MC, Rotterdam, South Holland, Netherlands
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCR253
引用
收藏
页码:S498 / S498
页数:1
相关论文
共 50 条
  • [31] Galactin-1, 3 and 9: Potential biomarkers in idiopathic pulmonary fibrosis and other interstitial lung diseases
    d'Alessandro, Miriana
    De Vita, Elda
    Bergantini, Laura
    Mazzei, Maria Antonietta
    di Valvasone, Simona
    Bonizzoli, Manuela
    Peris, Adriano
    Sestini, Piersante
    Bargagli, Elena
    Bennett, David
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2020, 282
  • [32] Long term experience with bosentan in patients with pulmonary arterial hypertension (PAH) associated with advanced idiopathic pulmonary fibrosis (IPF) and interstitial lung disease (ILD): A retrospective case series
    Raghu, G
    Hayes, J
    Spada, C
    Moniz, J
    Yang, S
    CHEST, 2005, 128 (04) : 218S - 219S
  • [33] Serial perfusion in native lungs in patients with idiopathic pulmonary fibrosis and other interstitial lung diseases after single lung transplantation
    Sokai, Akihiko
    Handa, Tomohiro
    Chen, Fengshi
    Tanizawa, Kiminobu
    Aoyama, Akihiro
    Kubo, Takeshi
    Ikezoe, Kohei
    Nakatsuka, Yoshinari
    Oguma, Tsuyoshi
    Hirai, Toyohiro
    Nagai, Sonoko
    Chin, Kazuo
    Date, Hiroshi
    Mishima, Michiaki
    CLINICAL TRANSPLANTATION, 2016, 30 (04) : 407 - 414
  • [34] HEALTH CARE AND ECONOMIC BURDEN OF PATIENTS WITH NONIDIOPATHIC PULMONARY FIBROSIS AND PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE (ILD) BY UNDERLYING ILD TYPE
    Nili, Mona
    Steffens, Andrea
    Anderson, Amy J.
    Johnson, Mary G.
    Brekke, Lee
    Veeranki, Sreenivas P.
    Olson, Amy L.
    CHEST, 2022, 162 (04) : 1226A - 1227A
  • [35] The difference of lung mechanics and chest kinematics in pulmonary rehabilitation of interstitial lung diseases versus idiopathic pulmonary fibrosis
    Kerti, Maria
    Bayer, Beatrix
    Kelemen, Krisztina
    Varga, Janos Tamas
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [36] A Cohort of Patients with a Progressive Fibrosing Phenotype of Interstitial Lung Disease (PF-ILD) Other Than Idiopathic Pulmonary Fibrosis: The Progress Study
    Cottin, V.
    Larrieu, S.
    Fabre, C.
    Si-Mohamed, S.
    Ahmad, K.
    Boussel, L.
    Brevet, M.
    Marque, S.
    Revel, D.
    Thivolet-Bejui, F.
    Traclet, J.
    Zeghmar, S.
    Maucort-Boulch, D.
    Nasser, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [37] CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline
    Balestro, Elisabetta
    Castelli, Gioele
    Bernardinello, Nicol
    Cocconcelli, Elisabetta
    Biondini, Davide
    Fracasso, Federico
    Rea, Federico
    Saetta, Marina
    Baraldo, Simonetta
    Spagnolo, Paolo
    CHRONIC RESPIRATORY DISEASE, 2020, 17
  • [38] A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases
    Furukawa, Taiki
    Oyama, Shintaro
    Yokota, Hideo
    Kondoh, Yasuhiro
    Kataoka, Kensuke
    Johkoh, Takeshi
    Fukuoka, Junya
    Hashimoto, Naozumi
    Sakamoto, Koji
    Shiratori, Yoshimune
    Hasegawa, Yoshinori
    RESPIROLOGY, 2022, 27 (09) : 739 - 746
  • [39] Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases
    Dhooria, Sahajal
    Agarwal, Ritesh
    Gupta, Dheeraj
    LUNG INDIA, 2015, 32 (01) : 4 - +
  • [40] Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases
    King, Christopher
    Nathan, Steven D.
    CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (05) : 466 - 473